Weekly Ferrous Sulfate — Competitive Intelligence Brief

Weekly Ferrous Sulfate (Weekly Ferrous Sulfate) competitive landscape: 6 comparators, recent regulatory actions, upcoming PDUFA, patent timeline. Class: Iron supplement. Area: Hematology.

marketed Iron supplement Iron (Fe2+) for hemoglobin synthesis Hematology Small molecule

Target snapshot

Weekly Ferrous Sulfate (Weekly Ferrous Sulfate) — Instituto de Desarrollo e Investigaciones Pediátricas Prof. Dr. Fernando E. Viteri. Ferrous sulfate provides bioavailable iron to replenish depleted iron stores and restore hemoglobin synthesis.

Comparator set (6 drugs)

Drug	Generic	Sponsor	Phase	Class	Target	Approval / PDUFA
Weekly Ferrous Sulfate TARGET	Weekly Ferrous Sulfate	Instituto de Desarrollo e Investigaciones Pediátricas Prof. Dr. Fernando E. Viteri	marketed	Iron supplement	Iron (Fe2+) for hemoglobin synthesis
Erythropoietin subcutaneously and Iron intravenously	Erythropoietin subcutaneously and Iron intravenously	Catharina Ziekenhuis Eindhoven	marketed	Erythropoiesis-stimulating agent combined with iron supplement	Erythropoietin receptor (EPOR); iron as cofactor for hemoglobin synthesis
FerroGrad by Abbott	FerroGrad by Abbott	Clinica Fabia Mater	marketed	Iron supplement
Iron supplement A	Iron supplement A	Tanabe Pharma Corporation	marketed	Iron supplement	Iron (Fe2+/Fe3+)
Iron protein succinylate oral solution	Iron protein succinylate oral solution	Lee's Pharmaceutical Limited	marketed	Iron supplement
ARM A : IV iron + epoietin zeta	ARM A : IV iron + epoietin zeta	Centre Francois Baclesse	marketed	Iron supplement + Erythropoiesis-stimulating agent (ESA)	Erythropoietin receptor (EPOR); iron as cofactor for hemoglobin synthesis
Daily Ferrous Sulfate	Daily Ferrous Sulfate	Instituto de Desarrollo e Investigaciones Pediátricas Prof. Dr. Fernando E. Viteri	marketed	Iron supplement

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape (Iron supplement class)

1. Tanabe Pharma Corporation · 4 drugs in this class
2. Instituto de Desarrollo e Investigaciones Pediátricas Prof. Dr. Fernando E. Viteri · 2 drugs in this class
3. Universidade Federal Fluminense · 2 drugs in this class
4. Clinica Fabia Mater · 1 drug in this class
5. GlaxoSmithKline · 1 drug in this class
6. Hatem AbuHashim · 1 drug in this class
7. Hospital Universitari Vall d'Hebron Research Institute · 1 drug in this class
8. Laboratoire Innotech International · 1 drug in this class
9. Lee's Pharmaceutical Limited · 1 drug in this class
10. Milton S. Hershey Medical Center · 1 drug in this class